Submission of Blank Large Shareholding Report


  • This document is a template for a report on large shareholdings, and it is a blank report with no specific figures or changes.
  • All tables in the report are empty, lacking key information such as the reporter, number of shares held, and holding ratio.
  • The only specific note is that 'total assets, etc. are based on financial statements as of end of 2025'.
  • Therefore, this report has no impact on stock price and is a neutral event.

KOSDAQ Filing Information


  • Filing: Report on Large Shareholding (General)
  • Company: Keeps Pharma (256940)
  • Submission: Dum Mim
  • Receipt: 05-14-2026